Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells

Differentiation induction is currently considered as an alternative strategy for treating chronic myelogenous leukemia (CML). Our previous work has demonstrated that Sprouty-related EVH1 domainprotein2 (Spred2) was involved in imatinib mediated cytotoxicity in CML cells. However, its roles in growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuefeng, Liu, Xiaoyun, Xiao, Fengjun, Xue, Shuya, Xu, Qinqin, Yin, Yue, Sun, Huiyan, Xu, Jie, Wang, Hengxiang, Zhang, Qunwei, Wang, Hua, Wang, Lisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331423/
https://www.ncbi.nlm.nih.gov/pubmed/25688862
http://dx.doi.org/10.1371/journal.pone.0117573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331423/
https://www.ncbi.nlm.nih.gov/pubmed/25688862
http://dx.doi.org/10.1371/journal.pone.0117573

Ejemplares similares